查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363087

ADME毒性測試市場規模、佔有率、趨勢分析報告：按技術、按用途、按方法、細分趨勢，2023-2030

ADME Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture, OMICS Tech), By Application (Neurotoxicity, Renal Toxicity), By Method (Cellular Assay, In-Silica), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

ADME 毒理學測試市場成長與趨勢：

根據Grand View Research, Inc.的最新報告，預計到2030年，全球ADME毒性測試市場規模將產生192.1億美元的收益，預測期內年複合成長率為10.2%。

製藥公司採用更好的毒性測試方法，增加檢查階段藥物失效的需求，預計將推動市場產生收入。

吸收、分佈、代謝和排泄（ADME）毒性測試用於臨床試驗中，檢測分子因化學、藥物、遺傳或其他要素引起的毒性反應或全身性反應。這些毒理學測試程序有助於開發有效的藥物，限制或預防給藥後體內的毒性反應。毒性水平是根據在接近自然條件下進行的一系列測試的結果確定的，代表藥物和宿主之間的近即時反應。

截至2017年，大約43.0%的ADME毒性測試領域是基於細胞培養技術進行的。細胞培養技術因其接近自然條件和在細胞層面獲得準確結果等優點而被廣泛採用。

這些測定是在可能發生幾種類型的毒性反應或毒性反應的系統上進行的。毒性試驗包括全身性毒性、腎毒性、肝毒性、神經毒性以及活體組織中可能發生的其他毒性。測試方法的趨勢目前正在進行中，並且可能會被許多開發藥物分子的公司所採用。預計這將加速藥物研發進程並促進市場成長。

ADME 毒理學測試市場報告亮點

  • 階段藥物失敗比例不斷上升推動了市場的發展，導致藥物開發的寶貴時間和投資損失。此外，預計 OMICS 技術的成長和採用的增加將在未來年度增加產生收入。
  • 北美是 ADME 毒性測試的最大市場，因為許多製藥公司競相將新分子商業性市場。
  • 隨著許多跨國和本地公司有意進入亞太和拉丁美洲的新興市場，該市場有望顯著成長。我們也致力於透過創新和成長機會提高我們在市場中的地位。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 ADME 毒理學測試市場變數、趨勢和範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • ADME毒理學測試市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 ADME毒性測試：技術估算與趨勢分析

  • ADME毒理學測試市場：要點
  • ADME 毒理學測試市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 細胞培養
  • 高通量
  • 分子影像
  • 組學技術

第5章 ADME 毒理學測試市場：按用途估算和趨勢分析

  • ADME毒理學測試市場：要點
  • ADME 毒理學測試市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 全身毒性
  • 腎毒性
  • 肝毒性
  • 神經毒性
  • 其他毒性

第6章 ADME毒性測試市場：方法估算及趨勢分析

  • ADME毒理學測試市場：要點
  • ADME 毒理學測試市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 細胞測定
  • 生化測定
  • 矽膠
  • 體外

第7章 ADME毒理學測試市場：區域估算與趨勢分析

  • 區域展望
  • ADME毒理學測試市場（按地區）：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Thermo Fisher Scientific Inc.
    • Promega Corporation
    • Agilent Technologies, Inc.
    • Curia Global, Inc.
    • Dassault Systemes
    • Beckman Coulter, Inc., (Danaher)
    • Catalent, Inc
    • Charles River Laboratories
    • Labcorp Drug Development
    • Eurofins Scientific
    • GE HealthCare
    • Miltenyi Biotec
    • IQVIA Inc
Product Code: GVR-2-68038-627-1

ADME Toxicology Testing Market Growth & Trend:

The global ADME toxicology testing market size is expected to generate a revenue of USD 19.21 billion by 2030, according to a new report by Grand View Research, Inc.., exhibiting a CAGR of 10.2% during the forecast period. Factors such as increased need to check late-stage drug failures with the adoption of more appropriate toxicity testing methods by pharmaceutical companies are expected to aid revenue generation for the market.

Absorption, distribution, metabolism, and excretion (ADME) toxicology testing is used to test toxic reactions caused by molecules in clinical trials on factors and systemic reactions such as chemical, pharmaceutical, and genetic. These toxicology testing procedures help in effective drug development, which limits or prevents toxic reactions to the body when administered. Toxicity levels are decided on the results of a series of tests conducted in near-natural conditions, which represent almost real-time reactions between the drug and the host.

As of 2017, approximately 43.0% of ADME toxicology testing areas carried out are based on cell culture tech. Cell culture technology is adopted widely owing to advantages such as near-natural conditions and accurate results obtained at a cellular level.

These assays are conducted for several types of toxic reactions or systems where toxic reactions might take place. Some of the toxicity tests are systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and other toxicities that might result in living tissue. Advancements in testing methods are underway and this trend is likely to be picked up by many companies developing drug molecules. This will speed up the drug discovery process and boost the market growth.

ADME Toxicology Testing Market Report Highlights:

  • The market is driven by an increasing ratio of late-stage drug failures, resulting in loss of valuable time and investment for drug development. Growth and increasing adoption of OMICS technology is also expected to boost revenue generation in the coming years
  • North America is the largest market for ADME toxicology testing owing to the presence of a large number of pharmaceutical companies competing for the commercial launch of novel molecules
  • Developing regions of Asia Pacific and Latin America are set to grow considerably as many multinational and local players are striving to enter the market. They are also looking to improve their hold in markets that present innovation and growth opportunities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Application
    • 1.1.3. Method
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
    • 2.2.3. Method outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. ADME Toxicology Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. ADME Toxicology Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. ADME Toxicology Testing: Technology Estimates & Trend Analysis

  • 4.1. ADME Toxicology Testing Market: Key Takeaways
  • 4.2. ADME Toxicology Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Cell Culture
    • 4.3.1. Cell Culture market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. High Throughput
    • 4.4.1. High throughput market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Molecular Imaging
    • 4.5.1. Molecular imaging market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. OMICS Technology
    • 4.6.1. OMICS technology market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. ADME Toxicology Testing Market: Application Estimates & Trend Analysis

  • 5.1. ADME Toxicology Testing Market: Key Takeaways
  • 5.2. ADME Toxicology Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Systemic Toxicity
    • 5.3.1. Systemic toxicity market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Renal Toxicity
    • 5.4.1. Renal toxicity market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Hepatotoxicity
    • 5.5.1. Hepatotoxicity market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Neurotoxicity
    • 5.6.1. Neurotoxicity market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Other Toxicities
    • 5.7.1. Other toxicities market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. ADME Toxicology Testing Market: Method Estimates & Trend Analysis

  • 6.1. ADME Toxicology Testing Market: Key Takeaways
  • 6.2. ADME Toxicology Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Cellular Assay
    • 6.3.1. Cellular assay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Biochemical Assay
    • 6.4.1. Biochemical assay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. In-Silica
    • 6.5.1. In-silica market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Ex-vivo
    • 6.6.1. Ex-vivo market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. ADME Toxicology Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. ADME Toxicology Testing Market by Region: Key Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Thermo Fisher Scientific Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Promega Corporation
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Agilent Technologies, Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Curia Global, Inc.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Dassault Systemes
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Beckman Coulter, Inc., (Danaher)
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Catalent, Inc
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Charles River Laboratories
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Labcorp Drug Development
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Eurofins Scientific
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. GE HealthCare
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. Miltenyi Biotec
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
    • 8.2.13. IQVIA Inc
      • 8.2.13.1. Company overview
      • 8.2.13.2. Financial performance
      • 8.2.13.3. Product benchmarking
      • 8.2.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 3 North America ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 5 North America ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 7 U.S. ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 9 Canada ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 10 Canada ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 12 Europe ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 13 Europe ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 15 Europe ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 17 Germany ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 19 UK ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 20 UK ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 22 France ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 23 France ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 24 France ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 25 Italy ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Italy ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 28 Spain ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Spain ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 31 Sweden ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Sweden ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 34 Norway ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Norway ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 37 Denmark ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Denmark ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Japan ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 47 China ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 48 China ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 49 China ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 50 India ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 51 India ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 52 India ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 53 Australia ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Australia ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 56 Thailand ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Thailand ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 59 South Korea ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 60 South Korea ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 62 Latin America ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Latin America ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 65 Latin America ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Brazil ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 69 Mexico ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 70 Mexico ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 72 Argentina ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Argentina ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 80 South Africa ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 85 UAE ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 86 UAE ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 88 Kuwait ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 89 Kuwait ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait ADME toxicology testing market, by method, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 ADME toxicology testing: Market outlook
  • Fig. 9 ADME toxicology testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 ADME toxicology testing market driver impact
  • Fig. 15 ADME toxicology testing market restraint impact
  • Fig. 16 ADME toxicology testing market strategic initiatives analysis
  • Fig. 17 ADME toxicology testing market: Technology movement analysis
  • Fig. 18 ADME toxicology testing market: Technology outlook and key takeaways
  • Fig. 19 Cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 High throughput market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Molecular imaging market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 OMICS technology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 ADME toxicology testing market: Application movement analysis
  • Fig. 24 ADME toxicology testing market: Application outlook and key takeaways
  • Fig. 25 Systemic toxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Renal toxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Hepatotoxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Neurotoxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Other toxicities market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 ADME toxicology testing market: Method movement analysis
  • Fig. 31 ADME toxicology testing market: Method outlook and key takeaways
  • Fig. 32 Cellular assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Biochemical assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 In-silica market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Ex-vivo market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Global ADME toxicology testing market: Regional movement analysis
  • Fig. 37 Global ADME toxicology testing market: Regional outlook and key takeaways
  • Fig. 38 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)